Bio Green Med Solution (BGMS) Capital Expenditures Growth (1y) (2013 - 2023)
Powered by 
Analysis
Bio Green Med Solution (BGMS) Capital Expenditures Growth (1y) (2013 - 2023) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.60 Bn | 132.75 Bn | 2.84 Bn | -22.99% |
| 2 | Regeneron Pharmaceuticals | 87.04 Bn | 79.04 Bn | 3.93 Bn | 9.68% |
| 3 | Argenx Se | 64.93 Bn | 59.75 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.38 Bn | 53.25 Bn | 52.00 Mn | 1,133.33% |
| 5 | Revolution Medicines | 44.27 Bn | 44.27 Bn | - | - |
| 6 | BeOne Medicines | 39.98 Bn | 34.88 Bn | 1.53 Bn | -37.81% |
| 7 | Alnylam Pharmaceuticals | 35.21 Bn | 31.90 Bn | 992.69 Mn | 142.64% |
| 8 | Royalty Pharma | 28.01 Bn | 27.17 Bn | - | 22,433.30% |
| 9 | Insmed | 27.33 Bn | 26.17 Bn | 358.27 Mn | -73.62% |
| 10 | Bio Green Med Solution | 5.04 Mn | 1.25 Mn | 79,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2023 | 50.00% |
| Jun 30, 2022 | 104.84% |
| Mar 31, 2022 | -94.87% |
| Dec 31, 2021 | -95.24% |
| Sep 30, 2021 | -82.00% |
| Mar 31, 2021 | 1,850.00% |
| Dec 31, 2020 | 1,300.00% |
| Sep 30, 2020 | 1,150.00% |
| Mar 31, 2020 | 100.00% |
| Dec 31, 2019 | -50.00% |
| Sep 30, 2019 | 100.00% |
| Jun 30, 2019 | -88.89% |
| Mar 31, 2019 | -90.91% |
| Dec 31, 2018 | 200.00% |
| Sep 30, 2018 | -77.78% |
| Mar 31, 2018 | 1,000.00% |
| Dec 31, 2015 | -71.43% |
| Sep 30, 2015 | -95.78% |
| Jun 30, 2015 | -76.47% |
| Mar 31, 2015 | -54.84% |